pazopanib and Carcinoma--Basal-Cell

pazopanib has been researched along with Carcinoma--Basal-Cell* in 1 studies

Other Studies

1 other study(ies) available for pazopanib and Carcinoma--Basal-Cell

Article	Year
Clinical Response to Pazopanib in a Patient With KDR-Mutated Metastatic Basal Cell Carcinoma. JAMA dermatology, 2017, 06-01, Volume: 153, Issue:6 Topics: Carcinoma, Basal Cell; DNA Mutational Analysis; DNA, Neoplasm; Humans; Indazoles; Male; Middle Aged; Mutation; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Skin Neoplasms; Sulfonamides; Vascular Endothelial Growth Factor Receptor-2	2017

Article

Year

Clinical Response to Pazopanib in a Patient With KDR-Mutated Metastatic Basal Cell Carcinoma.

JAMA dermatology, 2017, 06-01, Volume: 153, Issue:6

Topics: Carcinoma, Basal Cell; DNA Mutational Analysis; DNA, Neoplasm; Humans; Indazoles; Male; Middle Aged; Mutation; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Skin Neoplasms; Sulfonamides; Vascular Endothelial Growth Factor Receptor-2

2017